Drug
Biib017
Biib017: highest development phase Phase 3, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIIB017 (peginterferon beta-1a) NCT03958877 | Phase 3 | Multiple Sclerosis, Relapsing-Remitting |
Latest
No recent events.
Follow Biib017 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.